Brief: Addex Therapeutics And SIB Receive Innosuisse Grant
Aug 27 (Reuters) - Addex Therapeutics Ltd ADXN.S :
* ADDEX AND SIB SWISS INSTITUTE OF BIOINFORMATICS RECEIVE
INNOSUISSE GRANT TO REPURPOSE POTENT DOPAMINE ANTAGONIST USING
COMPUTATIONAL MODELLING
Source text for Eikon: ID:nGNE4lwtBc
Further company coverage: ADXN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))